Page 59 - GlaxoSmithKline Pharmaceuticals AR 2012

55
Notes to the Financial Statements for the year ended 31st December, 2012 — continued
Rupees in lakhs
(ix) Net asset/liability recognised in the Balance Sheet
(including experience adjustment impact)
2012 2011 2010 2009 2008
Gratuity
Defined benefit obligation .. .. .. 45,89.25 47,30.42 46,72.26 28,05.36 32,94.62
Plan assets .. .. .. .. 28,68.72 31,41.46 32,27.37 29,45.50 26,13.10
Deficit / (Surplus) .. .. .. .. 17,20.53 15,88.96 14,44.89 (1,40.14) 6,81.52
Experience adjustments on plan liabilities 2,59.55 1,87.34 1,58.29 2,19.12 1,99.47
Experience adjustments on plan assets (1,78.15) 49.91 1,75.62 3,25.63 (16.85)
Post retirement medical and other benefits
Defined benefit obligation .. .. .. 36,52.80 29,86.89 28,06.34 22,13.01 30,13.60
Plan assets .. .. .. .. .. — — — — —
Deficit / (Surplus) .. .. .. .. 36,52.80 29,86.89 28,06.34 22,13.01 30,13.60
Experience adjustments on plan liabilities 5,02.91 2,72.60 5,20.13 (77.38) 74.05
Experience adjustments on plan assets — — — — —
47 The Company has only one reportable segment which is Pharmaceuticals. Accordingly, no separate disclosures of segment information
have been made.
48 Related Party disclosures
Related party disclosures, as required by Accounting Standard 18, “Related Party Disclosures”, notified under sub-section (3C)
of Section 211 of the Companies Act, 1956 are given below:
1 Relationships (during the year):
(i) Shareholders (the GlaxoSmithKline (GSK) Group shareholding) in the Company
Glaxo Group Limited, U.K.
Eskaylab Limited, U.K.
Burroughs Wellcome International Limited, U.K.
Castleton Investment Limited, Mauritius
Holding company / ultimate holding company of the above shareholders *
GlaxoSmithKline plc, U.K.
GlaxoSmithKline Finance plc, U.K.
SmithKline Beecham Limited, U.K.
Wellcome Limited, U.K.
The Wellcome Foundation Limited, U.K.
Wellcome Consumer Healthcare Limited, U.K.
* no transactions during the year
(ii) Subsidiary of the Company
Biddle Sawyer Limited, a wholly owned subsidiary of the Company
(iii) Other related parties in the GlaxoSmithKline (GSK) Group where common control exists and with whom the Company had
transactions during the year:
SmithKline Beecham Private Limited, Sri Lanka
GlaxoSmithKline Pakistan Limited, Pakistan
GlaxoSmithKline Asia Private Limited, India
GlaxoSmithKline Consumer Healthcare Limited, India
GlaxoSmithKline Biologicals S.A., Belgium
GlaxoSmithKline Services Unlimited, U.K.
GlaxoSmithKline Export Limited, U.K.
SmithKline Beecham Pharmaceuticals R & D, U.S.
Glaxo Operations UK Limited, U.K
GlaxoSmithKline Pte Limited, Singapore
GlaxoSmithKline Australia Pty Limited, Australia
GlaxoSmithKline Trading Services Limited, Ireland
GlaxoSmithKline Limited, Hong Kong
GlaxoSmithKline LLC, U.S.A
GlaxoSmithKline Limited, Kenya
Stiefel India Private Limited, India
Glaxo Wellcome Ceylon Ltd., Sri Lanka
US Pharmaceuticals, U.S.A.
GlaxoSmithKline Ilaclari Sanayi ve Ticaret AS, Turkey
GlaxoSmithKline Manufacturing SPA, Italy